Co-Diagnostics, Inc. Common Stock (CODX) — Free Cash Flow Generation Index
Co-Diagnostics, Inc. Common Stock (CODX) has a Free Cash Flow Generation Index of 0.79x as of September 2022. Free cash flow of $888.27K represents 1% of operating cash flow ($1.12 Million). Explore CODX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Co-Diagnostics, Inc. Common Stock Free Cash Flow Generation Index (2020–2022)
Historical FCF Generation Index trend for Co-Diagnostics, Inc. Common Stock across 3 annual periods. For the full cash flow conversion analysis, see Co-Diagnostics, Inc. Common Stock operating cash flow efficiency.
Annual Free Cash Flow Generation for Co-Diagnostics, Inc. Common Stock (2020–2022)
Year-by-year Free Cash Flow Generation Index for Co-Diagnostics, Inc. Common Stock. Check CODX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.78x | $5.14 Million | $6.57 Million | $1.43 Million | ▼ -20.4% |
| 2021 | 0.98x | $40.41 Million | $41.08 Million | $669.46K | ▲ +1.2% |
| 2020 | 0.97x | $27.39 Million | $28.17 Million | $774.40K | — |